Wednesday, October 12, 2011 (7:30 AM - 9:30 AM)
Time: 7:30 – 9:30 AMRegistration 7:30 AMProgram and Panel 8:00-9:30 AMLocation: University of Washington Center for Urban Horticulture3501 NE 41st StreetSeattle, WA 98195 Moderator: Lee Huntsman, PhD, Executive Director, Life Sciences Discovery FundConfirmed speakers:Tom Clement, President & CEO, AqueductTom Fritz, President & CEO, Inland Northwest Health ServicesMike Gallatin, Former President, Calistoga; former Executive, IcosJeffrey Herz, President & Founder, AlgomedixGary Jones, MD, Chief Medical Officer and Director of Clinical Development, C3 Research Associates
Translational Medicine is the process of turning biological discoveries into drugs and/or medical devices that can help patients better, faster, and cheaper. In the case of drug discovery and development, translational research typically refers to the translation of laboratory-based research into therapies for patients. In the case of medical devices, translational process focuses on the translation of problems observed at bedside into device therapies for patients. This may be couched at "bedside to bench" definition.
In this program we will discuss formation of a company, manufacturability, regulatory, and reimbursement strategies all within the context of translational medicine.Registration Fees:WBBA Member- $35.00 Non-Member- $50.00 Academia, Nonprofit, Student- $25.00
3501 NE 41st St
Seattle, WA 98195 United States
© 2012 Washington Biotechnology & Biomedical Association